Trial Publication information Patient characteristics Diseases Ref.
  Author Year Country Total number average age (years) Gender (M/F) NYHA FC (I/II/III/IV) ( Etiology)  
1 Abdullah et al. 2001 UK 19(16$) 67 13/3 0/9/5/2 IHD, DCM 8
2 Thomaset al. 2001 USA 9 46 7/2 1/2/5/1 IDCM 9
3 Colinet al. 2002 UK 11 67.5 10/1 0/6/5/0 CAD 10
4 Wolfram et al. 2002 Germany 19 57.2 19/0 - ICM, DCM 11
5 15(14$) 68.4 15/0 - ICM, DCM 11
6 Gavinet al. 2004 UK 50(43$) 67 34/9 0/31/12/0 IHD, CM, VHD,et al. 12
7 Jacobet al. 2006 K 30(29$) 69.7 25/5 0/18/12/0 IHD 13
8 Stephanet al. 2006 Germany 26 65.3 25/1 0/0/14/6 ICM 14
9 Dimitriset al. 2010 Greece 42 67 39/3 0/35/7/0 IHD, NIHD 15
10 Douglaset al. 2010 Chile 74 59.5 61/13 0/41/31/2 IHD, IDCM,et al. 16
11# Gamelaet al. 2010 Egypt 79 - - 0/ - / - /0 IHD, IDCM 17
12# S von Haehling 2010 Germany 16 68 - 0/10/5/1 IHD, NIHD 18
13 Dimitriset al. 2011 Greece 60 65.3 55/5 0/49/11/0 IHD, NIHD 19
14 Doganet al. 2012 Turkey 42(39$) - 25/14 - /- / - /0 IDCM 20
15 Glennet al. 2012 USA 16(13$) 47.8 9/4 0/10/3/0 NICM 21
16 Chao Liu et al. 2013 China 34 50.2 30/4 0/0/5/29 CAD, IDCM 22
17 Sushmaet al. 2013 UK 66(60$) 64.5 54/6 - IHD 23
18* Awsanet al. 2010 UK 65(60$) 64.6 50/10 9/42/9/0 CAD 24
19* Narasimharajapuraet al. 2011 UK 80 65.5 64/16 - CAD 25
# Healthy individuals as control
$The number of patients eligible for the assessment of clinical outcomes
* Angina was the study object
- No related information was provided.
et al.. Not all etiologies were provided.
ACM: alcoholic cardiomyopathy; CAD: coronary artery disease;CM: cardiomyopathy; DCM: dilated cardiomyopathy; ICM: ischemic cardiomyopathy; IDCM: idiopathic dilated cardiomyopathy; IHD:ischemic heart disease; NICM: non-ischemic cardiomyopathy; VHD:valvular heart disease
Table 1: Characteristics of the included clinical trials.